geniposide has been researched along with Angiogenesis, Pathologic in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 6 (85.71) | 2.80 |
Authors | Studies |
---|---|
Bu, YH; Deng, R; Gui, BJ; Liu, J; Rong, GX; Wang, Y; Wu, H; Zhang, H | 1 |
Bu, Y; Deng, R; Wang, Y; Wu, H | 2 |
Chen, F; Feng, Y; Guo, W; Lao, L; Man, K; Tan, HY; Tsao, SW; Wang, N; Zhang, C; Zhong, Z | 1 |
Bu, Y; Deng, R; Sun, M; Wang, Y; Wu, H; Zhang, H; Zhang, Z | 1 |
Bu, YH; Dai, XJ; Deng, R; Sun, MH; Wang, MD; Wang, RH; Wang, Y; Wu, H; Zhang, H | 1 |
Cheung, F; Feng, Y; Hong, M; Lao, L; Nagamatsu, T; Tan, HY; Wang, N | 1 |
7 other study(ies) available for geniposide and Angiogenesis, Pathologic
Article | Year |
---|---|
Geniposide alleviates VEGF-induced angiogenesis by inhibiting VEGFR2/PKC/ERK1/2-mediated SphK1 translocation.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Endothelial Cells; Humans; Iridoids; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Phosphotransferases (Alcohol Group Acceptor); Rats; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2022 |
The anti-angiogenesis mechanism of Geniposide on rheumatoid arthritis is related to the regulation of PTEN.
Topics: Angiogenesis Inducing Agents; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Human Umbilical Vein Endothelial Cells; Humans; Iridoids; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Signal Transduction | 2022 |
Geniposide restricts angiogenesis in experimentary arthritis via inhibiting Dnmt1-mediated PTEN hypermethylation.
Topics: Angiogenesis Inhibitors; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Human Umbilical Vein Endothelial Cells; Humans; Iridoids; Neovascularization, Pathologic; PTEN Phosphohydrolase; Rats | 2022 |
Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF-1α-independent VEGF expression and angiogenesis in hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Endothelial Cells; Hypoxia-Inducible Factor 1, alpha Subunit; Iridoids; Liver Neoplasms; Mice; Myeloid Differentiation Factor 88; Neovascularization, Pathologic; Toll-Like Receptor 4; Vascular Endothelial Growth Factor A | 2020 |
Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis.
Topics: Animals; Cell Survival; Cells, Cultured; Drug Delivery Systems; Iridoids; Lysophospholipids; Male; Neovascularization, Pathologic; Phosphotransferases (Alcohol Group Acceptor); Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2020 |
Geniposide downregulates the VEGF/SphK1/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro.
Topics: Adaptor Proteins, Signal Transducing; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Endothelial Cells; Fibroblasts; Humans; Iridoids; Neovascularization, Pathologic; Signal Transduction; Sphingosine-1-Phosphate Receptors; Synovial Membrane; Vascular Endothelial Growth Factor A | 2021 |
Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Berberine; Carcinoma, Hepatocellular; Cell Line, Tumor; Drugs, Chinese Herbal; Elongation Factor 2 Kinase; Female; Flavonoids; Humans; Iridoids; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Phytotherapy; Xenograft Model Antitumor Assays | 2015 |